🇺🇸 FDA
Patent

US 10815271

Structure-based peptide inhibitors of alpha-synuclein aggregation

granted A61KA61K38/00A61P

Quick answer

US patent 10815271 (Structure-based peptide inhibitors of alpha-synuclein aggregation) held by The Regents of the University of California expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61P, A61P25/16